Save More Lives: Broadening Buprenorphine Access Amid New DEA Controlled Substances Rules from buprenorphine requirements Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 36 min 14 sec ✓ Published: 22-Jun-2023
Description: Blair Walker, M.D., and John Weems, M.D., FASAM, review the updated Drug Enforcement Administration requirements for prescribing buprenorphine for opioid use disorder and pain management.nnWalker serves as chief of psychiatry at Dell Seton Medical Center and is an assistant professor in the Department of Psychiatry and Behavioral Sciences at Dell Med. Weems is the associate director of addiction medicine for the CommUnityCare Health Centers. He is also an assistant professor in the Department of
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)